| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.64B | 3.65B | 3.81B | 3.65B | 3.45B |
| Gross Profit | 807.87M | 843.34M | 850.72M | 715.91M | 701.91M |
| EBITDA | 579.64M | 575.76M | 577.59M | 476.87M | 473.46M |
| Net Income | 201.28M | 262.80M | 229.23M | 157.81M | 146.35M |
Balance Sheet | |||||
| Total Assets | 4.29B | 4.06B | 4.22B | 4.10B | 4.34B |
| Cash, Cash Equivalents and Short-Term Investments | 906.94M | 817.98M | 822.93M | 428.07M | 359.51M |
| Total Debt | 383.67M | 423.54M | 634.64M | 567.42M | 618.33M |
| Total Liabilities | 1.41B | 1.36B | 1.62B | 1.61B | 1.84B |
| Stockholders Equity | 2.84B | 2.67B | 2.55B | 2.45B | 2.42B |
Cash Flow | |||||
| Free Cash Flow | 214.90M | 252.58M | 395.73M | 205.93M | -132.85M |
| Operating Cash Flow | 498.69M | 448.09M | 581.88M | 432.49M | 183.59M |
| Investing Cash Flow | -271.11M | -94.26M | -225.41M | -240.80M | -351.20M |
| Financing Cash Flow | -132.10M | -305.02M | -5.87M | -110.37M | -23.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$146.88B | 14.49 | 24.34% | 4.35% | 16.74% | 24.19% | |
70 Outperform | HK$20.98B | 8.03 | 12.24% | 2.03% | 0.22% | -23.29% | |
65 Neutral | HK$34.60B | 11.09 | 12.26% | 1.39% | 11.26% | 15.82% | |
62 Neutral | HK$10.34B | 12.94 | 4.88% | 1.02% | 7.11% | 65.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | HK$11.95B | 74.08 | 8.45% | 1.37% | 24.97% | 0.39% | |
56 Neutral | HK$7.99B | -196.80 | -3.48% | ― | 6.97% | 76.15% |